about
Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized TrialsRationale and design of the Primary pREvention strategies at the community level to Promote Adherence of treatments to pREvent cardiovascular diseases trial number (CTRI/2012/09/002981)Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision makingEffects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic reviewTreatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data.Early mobilisation for patients following acute myocardiac infarction: a systematic review and meta-analysis of experimental studies.Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents.Assessment and reporting of perioperative cardiac risk by Canadian general internists: art or science?Statin use associates with a lower incidence of acute kidney injury after major elective surgeryBeta 2 antagonism in acute respiratory failureThe Safety of Eplerenone in Hemodialysis Patients: A Noninferiority Randomized Controlled TrialThe quality of randomized trial reporting in leading medical journals since the revised CONSORT statement.Incidence and timing of myocardial infarction after total joint arthroplasty.Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies.Optimal method of coronary revascularization in patients receiving dialysis: systematic review.How to use an article about a diagnostic test.Technology-Enabled Remote Monitoring and Self-Management - Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol.Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials.The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals.Kidney disease after preeclampsia: a systematic review and meta-analysis.The use of transcutaneous oximetry to predict complications of chronic wound healing: a systematic review and meta-analysis.The coronary CT angiography vision protocol: a prospective observational imaging cohort study in patients undergoing non-cardiac surgery.Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis.Cardiac biomarkers in the prediction of risk in the non-cardiac surgery setting.Myocardial injury after noncardiac surgery.Role of aspirin for prevention and treatment of perioperative cardiovascular events.Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview.Nitrous Oxide and Serious Long-term Morbidity and Mortality in the Evaluation of Nitrous Oxide in the Gas Mixture for Anaesthesia (ENIGMA)-II Trial.The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing non-cardiac surgery: a VISION sub-study.Clinician trialist rounds: 28. When RCT participants are lost to follow-up. Part 1: Why even a few can matter.Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: an international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery.Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.Implications of adjustment of high-sensitivity cardiac troponin T assay.Revisiting sample size: are big trials the answer?Reply to Letter to Editor: Orthopaedic Surgeons Prefer to Participate in Expertise-based Randomized Trials.Emerging designs in orthopaedics: expertise-based randomized controlled trials.Neuraxial block, death and serious cardiovascular morbidity in the POISE trial.Pros and cons of composite endpoints in anesthesia trials.The diagnosis of myocardial infarction in critically ill patients: an agreement study.Biomarkers for predicting serious cardiac outcomes at 72 hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes.
P50
Q22252532-4A41F333-F0F5-4E44-997D-D0C096A7CD16Q26859060-F3A7CC31-DC6D-4A10-A461-EF6C7D2FBD4FQ28191848-2F7628D4-6D9C-4800-83FD-A1A994159383Q28238881-79204A88-11FA-4CC0-95BC-191F6F3B1547Q31153770-481C7ED0-0DC0-43D9-841B-9B00076FABB5Q33438169-6887B943-408B-49B4-BA32-3F4ACBE9CBA5Q34282272-C93B61EA-4416-4CF9-A2D2-1074CD691AE2Q34743498-9E8DC145-E335-496C-A53B-6F10EC23884FQ34870827-645C8E75-2303-45AF-9B6B-4C570AB84189Q35561393-34E6023D-63D1-4FFC-85F8-50298EB2A3C4Q36025666-FBE3E757-6FB2-46D7-B66F-75EFF553CCA1Q36212911-7DB1A5EC-82BE-4A87-8157-96DBDD39C810Q36584448-B01BB0C9-D1C7-4018-ACD0-E7D4133F39E5Q36646577-637D1D69-B573-4D13-99B6-BDDF7F7E18D6Q37087920-DB4DA8C3-65BB-425F-B638-B8DDC640BA2DQ37190047-17946C98-805E-4083-8260-C1FCF8E8910EQ37207761-5858A448-AD48-40EF-88B5-51A35C9C5EA5Q37229530-5589433E-8F92-45AA-BDD0-FFE313E1C394Q37326055-00900B1F-66D9-4A03-8EF5-067FAE09D3B1Q37719886-5A2F0711-D791-47C2-AF42-57B704A63F3FQ37957273-988CA248-309D-4BC5-92FD-6DFC9DF43028Q38031459-136F2B10-21E3-498B-B892-39A0E0B92FD3Q38092970-48ACAAE7-D4B7-470A-878A-8DEA8436C8DBQ38205024-883B749F-437A-4D91-AF8D-5D968BAB232EQ38230139-7211C99F-D384-4DF5-B7F6-A6A9168A07B3Q38543306-76ED92C0-B886-4035-85CE-64C883D8A76BQ38543307-C449A05D-60E0-427D-B981-4D9D96452974Q38616380-6BA6B6F4-7D79-4926-B45A-7FA2151EB115Q41486348-63BDA00F-3815-4239-9961-0027AA49C459Q41503997-E230D636-5805-4F84-8615-7DCCC6969E61Q43796829-C3F00836-626C-4048-BC77-C5348D5B2991Q44370707-C2F33E3C-149F-43FF-8173-538D008113C9Q45104576-AA80640B-F0D9-4E68-BF22-46065F98C118Q45730058-4FAADC1D-64EF-430F-A8C2-EA08B5E05180Q45854983-B76FD8BB-0CB7-4580-A022-C96DC57D9953Q47970569-99D99D7E-CDE6-43CB-BEF1-1B3BBFCA9EEBQ48014589-AAA6A51C-6D90-447F-9B7B-26D788A1A2D5Q48331262-D057DE17-6A97-4E19-B56B-9EAA9AF25FF8Q51747915-D20FAA93-50E9-449C-A9DF-4E711FB541F8Q54558471-6941D671-2C6F-49DC-A473-055CE6BDF5E6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
P.J. Devereaux
@ast
P.J. Devereaux
@en
P.J. Devereaux
@es
P.J. Devereaux
@nl
P.J. Devereaux
@sl
type
label
P.J. Devereaux
@ast
P.J. Devereaux
@en
P.J. Devereaux
@es
P.J. Devereaux
@nl
P.J. Devereaux
@sl
prefLabel
P.J. Devereaux
@ast
P.J. Devereaux
@en
P.J. Devereaux
@es
P.J. Devereaux
@nl
P.J. Devereaux
@sl
P106
P1153
7004238603
P31
P496
0000-0003-2935-637X